Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Min, Jiang ^a,b   Liu, Liang ^a   Li, Xiaolan ^a   Jiang, Jianwu ^a   Wang, Jingtao ^a   Zhang, Bo ^a   Cao, Dengyi ^a   Yu, Dongdong ^a   Tao, Deding ^a   Hu, Junbo ^a   Gong, Jianping ^a   Xie, Daxing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAB2IP PROTEIN, HUMAN; FLUOROURACIL; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXALIPLATIN; PLATINUM COMPLEX;

ANIMAL; APOPTOSIS; CANCER STEM CELL; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; HT-29 CELL LINE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PROCEDURES; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE, NUDE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NF-KAPPA B; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RAS GTPASE-ACTIVATING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84946925522     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16578     Document Type: Article

References (49)

1. Center, M. M., Jemal, A., Smith, R. A. & Ward, E. Worldwide Variations in Colorectal Cancer. CA-Cancer J. Clin. 59, 366-378 (2009).
2. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10-29 (2012).
3. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428 (2009).
4. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
5. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
6. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 (1997).
7. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100, 3983-3988 (2003).
8. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 104, 10158-10163 (2007).
9. Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Research 63, 5821-5828 (2003).
10. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007).
11. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (2007).
12. Weichert, W., Knosel, T., Bellach, J., Dietel, M. & Kristiansen, G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57, 1160-1164 (2004).
13. Huang, E. H. et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69, 3382-3389 (2009).
14. Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142 (2006).
15. Hwang, W. L. et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141, 279-291, 291 e271-275 (2011).
16. Kurrey, N. K. et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27, 2059-2068 (2009).
17. Vesuna, F., Lisok, A., Kimble, B. & Raman, V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11, 1318-1328 (2009).
18. Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biology 11, 1487-U1236 (2009).
19. Chen, H., Toyooka, S., Gazdar, A. F. & Hsieh, J. T. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. Journal of Biological Chemistry 278, 3121-3130 (2003).
20. Chen, H., Tu, S. W. & Hsieh, J. T. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. Journal of Biological Chemistry 280, 22437-22444 (2005).
21. Dote, H. et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br. J. Cancer 92, 1117-1125 (2005).
22. Dote, H. et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clinical Cancer Research 10, 2082-2089 (2004).
23. Qiu, G. H. et al. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J. Hepatol. 46, 655-663 (2007).
24. Yano, M. et al. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int. J. Cancer 113, 59-66 (2005).
25. Min, W. et al. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circulation Research 102, 840-848 (2008).
26. Xie, D. X. et al. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 106, 19878-19883 (2009).
27. Zhang, H. F. et al. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. Journal of Biological Chemistry 279, 44955-44965 (2004).
28. Xie, D. X. et al. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 107, 2485-2490 (2010).
29. Min, J. et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappa B. Nat. Med. 16, 286-U282 (2010).
30. Batistatou, A., Charalabopoulos, A. & Charalabopoulos, K. Molecular basis of colorectal cancer. N Engl J Med 362, 1246 author reply 1246-1247 (2010).
31. Henderson, B. R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2, 653-660 (2000).
32. Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T. & Bienz, M. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J 22, 1101-1113 (2003).
33. Yang, J. et al. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem 281, 17751-17757 (2006).
34. Rowan, A. J. et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 97, 3352-3357 (2000).
35. Xie, D. et al. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA 107, 2485-2490 (2010).
36. Sparks, A. B., Morin, P. J., Vogelstein, B. & Kinzler, K. W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58, 1130-1134 (1998).
37. Li, Q. & Verma, I. M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2, 725-734 (2002).
38. Vallabhapurapu, S. & Karin, M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27, 693-733 (2009).
39. Brandi, G., Pantaleo, M. A., Biasco, G. & Paterini, P. Activated NF-kB in colorectal cancer: predictive or prognostic factor? J Clin Oncol 26, 1388-1389 author reply 1389-1390 (2008).
40. Sakamoto, K. et al. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 15, 2248-2258 (2009).
41. Scartozzi, M. et al. Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. J Clin Oncol 25, 3930-3935 (2007).
42. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2, 301-310 (2002).
43. Wu, Y. & Zhou, B. P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102, 639-644 (2010).
44. Li, C. W. et al. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72, 1290-1300 (2012).
45. Chua, H. L. et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26, 711-724 (2007).
46. Hinz, M. et al. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605-617 (2002).
47. Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25-38 (2013).
48. Deng, J. et al. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2, 323-334 (2002).
49. Cammareri, P. et al. Isolation and culture of colon cancer stem cells. Methods Cell Biol 86, 311-324 (2008).